Solid Biosciences Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.7% | -34.7% | -31.1% |
| FY2022 | -40.6% | -40.6% | -33.0% |
| FY2023 | -75.9% | -75.9% | -58.2% |
| FY2024 | -90.9% | -90.9% | -66.1% |
| FY2025 | -96.8% | -96.8% | -75.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -34.7% | -34.7% | -31.1% |
| FY2022 | -40.6% | -40.6% | -33.0% |
| FY2023 | -75.9% | -75.9% | -58.2% |
| FY2024 | -90.9% | -90.9% | -66.1% |
| FY2025 | -96.8% | -96.8% | -75.0% |